TrialJournal of clinical lipidology
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.
Patrick M Moriarty et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
182 papers cite itlatest 60 shown
pooled ittrialcites it